Kezar Life Sciences, Inc. Skyrocketed
Thu, Feb 06, 2020 at 05:30 PM
Kezar Life Sciences, Inc. (KZR:NASDAQ) jumped higher at $3.85, a gain of 28.2%. The stock appeared on our News Catalysts scanner on Tue 04 Feb 20 at 09:07 PM in the 'PUBLIC OFFERING' category. From Wed 15 Jan 20, the stock recorded 28.57% Up Days and 33.33% Green Days
The share price of the company has been moving sideways in recent weeks.
About Kezar Life Sciences, Inc. (KZR:NASDAQ)
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer.
Top 10 Gainers:
- SG Blocks, Inc. (SGBX:NASDAQ), 1795.1%
- Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ), 756.67%
- Yield10 Bioscience, Inc. (YTEN:NASDAQ), 56.48%
- Unisys Corporation (UIS:NYSE), 45.95%
- JanOne Inc. (JAN:NASDAQ), 32.05%
- Kezar Life Sciences, Inc. (KZR:NASDAQ), 28.17%
- CURO Group Holdings Corp. (CURO:NYSE), 26.67%
- Glu Mobile Inc. (GLUU:NASDAQ), 25.58%
- NantHealth, Inc. (NH:NASDAQ), 25.15%
- Lineage Cell Therapeutics, Inc. (LCTX:NYSEMKT), 21.3%